Metoprolol Tartrate Tablets USP — Class II drug recall D-0517-2024
Ongoing recall by Rubicon Research Private Limited, reported 2024-06-05, distributed nationwide. Presence of Foreign Substance: metal in tablet
| Recall number | D-0517-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Rubicon Research Private Limited, Ambarnath, India |
| Recall initiated | 2024-05-06 |
| Classified | 2024-05-29 |
| Reported by FDA | 2024-06-05 |
| Distributed | Nationwide (US) |
| Quantity | 11,664 bottles |
| NDC | 52817-0358, 52817-0358-10, 52817-0358-50, 52817-0359, 52817-0359-10, 52817-0359-50, 52817-0360, 52817-0360-00, 52817-0360-10, 52817-0361, 52817-0361-00, 52817-0361-10, 52817-0362, 52817-0362-00, 52817-0362-10 |
| Lot numbers | 231037H1 |
| Expiration dates | 2027-06 |
Product
Metoprolol Tartrate Tablets USP, 25mg, 1000 count bottle, Rx only, distributed by: TruPharma, LLC, Tampa, FL 33609, Manufactured by: Rubicon Research Private Limited, Ambernath Dist Thane 421506 India, NDC 52817-360-00
Reason for recall
Presence of Foreign Substance: metal in tablet
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0517-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.